Published in:
01-06-2013 | original research
Provider advice about smoking cessation and pharmacotherapy among cancer survivors who smoke: practice guidelines are not translating
Authors:
Karen M Emmons, PhD, Kim Sprunck-Harrild, MPH, MSW, Elaine Puleo, PhD, Janet de Moor, PhD
Published in:
Translational Behavioral Medicine
|
Issue 2/2013
Login to get access
ABSTRACT
Smoking among childhood and young adult cancer survivors may increase risk for late effects of treatment, and survivors need assistance in quitting. This paper reports on the prevalence of discussions between childhood cancer survivors and their health care providers about smoking cessation and pharmacotherapy and explores factors that are associated with these discussions. This is a longitudinal study that included 329 smokers who were childhood or young adult cancer survivors, recruited from five cancer centers in the USA and Canada. Fifty-five percent of smokers reported receiving advice to quit smoking from their regular provider during the study period, and only 36 % of smokers reported discussing pharmacotherapy with their provider. Receipt of advice was associated with being female and having a heavier smoking rate. Pharmacotherapy discussions were associated with readiness to quit, heavier smoking rate, and previous provider advice to quit. Health care providers are missing key opportunities to advise cancer survivors about cessation and evidence-based interventions. Systematic efforts are needed to ensure that survivors who smoke get the treatment that they need.